VDAC1 and Alzheimer disease: Among them, molecules named VBIT-3 and VIBT-4 have shown a pro-survival activity counteracting VDAC1 oligomerization in a pharmacological range of concentration and only in presence of VDAC1 overexpression, suggesting the pharmacological employment in AD (Ben-Hail et al., 2016).